Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir

References

• JohnstonCCoreyLCurrent concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract sheddingClin Microbiol Rev201629114916126561565
   PubMed Web of Science ®Google Scholar
• GuptaRWarrenTWaldAGenital herpesLancet200737096052127213718156035
   PubMed Web of Science ®Google Scholar
• CoreyLAdamsHGBrownZAHolmesKKGenital herpes simplex virus infections: clinical manifestations, course, and complicationsAnn Intern Med19839869589726344712
   PubMed Web of Science ®Google Scholar
• Lebrun-VignesBBouzamondoADupuyAGuillaumeJCLechatPChosidowOA meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaksJ Am Acad Dermatol200757223824617416440
   PubMed Web of Science ®Google Scholar
• KukhanovaMKKorovinaANKochetkovSNHuman herpes simplex virus: life cycle and development of inhibitorsBiochemistry (Mosc)201479131635165225749169
   PubMed Web of Science ®Google Scholar
• MattisonHRReichmanRCBenedettiJDouble-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpesAm J Med1988852A20253044086
   PubMed Web of Science ®Google Scholar
• ReichmanRCBadgerGJMertzGJTreatment of recurrent genital herpes simplex infections with oral acyclovirJAMA198425116210321076368877
   PubMed Web of Science ®Google Scholar
• TyringSWaldAZadeikisNDhaddaSTakenouchiKRorigRASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo-and valacyclovir-controlled, dose-finding studyJ Infect Dis201220571100111022351940
   PubMed Web of Science ®Google Scholar
• AokiFYTyringSDiaz-MitomaFGrossGGaoJHamedKSingle-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trialClin Infect Dis200642181316323085
   PubMed Web of Science ®Google Scholar
• CoreyLWaldAPatelROnce-daily valacyclovir to reduce the risk of transmission of genital herpesN Engl J Med20043501112014702423
   PubMed Web of Science ®Google Scholar
• CernikCGallinaKBrodellRTThe treatment of herpes simplex infections: an evidence-based reviewArch Intern Med200816811113718541820
   PubMedGoogle Scholar
• ReitanoMTyringSLangWValaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study GroupJ Infect Dis199817836036109728526
   PubMed Web of Science ®Google Scholar
• PolanskyHJavaherian A. 3-Econsystems: microRNAs, receptors, and latent viruses: some insights biology can gain from economic theoryFront Microbiol2016736927047480
   PubMed Web of Science ®Google Scholar
• PolanskyHJavaherianACommentary: the unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP betaFront Cell Infect Microbiol201556626442220
   PubMed Web of Science ®Google Scholar
• PolanskyHMicrocompetition with Foreign DNA and the Origin of Chronic DiseaseNew YorkCBCD Publishing2003
   Google Scholar
• PolanskyHItzkovitzEGene-Eden-VIR is antiviral: results of a post marketing clinical studyPharmacol Pharm201346A18
   Google Scholar
• PolanskyHItzkovitzEGene-Eden-VIR decreased physical and mental fatigue in a post marketing clinical study that followed FDA guidelines; results support microcompetition theoryPharmacol Pharm201453280290
   Google Scholar
• DouglasJMCritchlowCBenedettiJA double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infectionN Engl J Med198431024155115566328298
   PubMed Web of Science ®Google Scholar
• MertzGJLovelessMOLevinMJOral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research GroupArch Intern Med199715733433499040303
   PubMed Web of Science ®Google Scholar
• PatelRBodsworthNJWoolleyPValaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study GroupGenitourin Med19977321051099215091
   PubMedGoogle Scholar
• YavuzBBCankurtaranMHalilMDagliNKirkpanturARenal dysfunction after oral acyclovir treatment in a geriatric woman: a case reportScand J Infect Dis200537861161316138435
   PubMedGoogle Scholar
• BeckerBNFallPHallCRapidly progressive acute renal failure due to acyclovir: case report and review of the literatureAm J Kidney Dis19932246116158213806
   PubMed Web of Science ®Google Scholar
• BerryLVenkatesanPAciclovir-induced neurotoxicity: utility of CSF and serum CMMG levels in diagnosisJ Clin Virol201461460861025440915
   PubMed Web of Science ®Google Scholar
• Le CleachLTrinquartLDoGOral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patientsCochrane Database Syst Rev20148CD00903625086573
   PubMedGoogle Scholar
• LamNNWeirMAYaoZRisk of acute kidney injury from oral acyclovir: a population-based studyAm J Kidney Dis201361572372923312723
   PubMed Web of Science ®Google Scholar
• LaconiSMadedduMAPompeiRAutophagy activation and antiviral activity by a licorice triterpenePhytother Res201428121890189224919871
   PubMed Web of Science ®Google Scholar
• WangLYangRYuanBLiuYLiuCThe antiviral and antimicrobial activities of licorice, a widely-used Chinese herbActa Pharm Sin B20155431031526579460
   PubMed Web of Science ®Google Scholar
• SabouriGMMohammadiASafiallahySFaradmalJAziziMAhmadvandZThe effect of aqueous extract of glycyrrhiza glaba on herpes simplex virus 1Jundishapur J Microbiol201477e1161625368801
   PubMed Web of Science ®Google Scholar
• HungPYHoBCLeeSYHouttuynia cordata targets the beginning stage of herpes simplex virus infectionPLoS One2015102e011547525643242
   PubMed Web of Science ®Google Scholar
• OriharaYHamamotoHKasugaHShimadaTKawaguchiYSekimizuKA silkworm baculovirus model for assessing the therapeutic effects of antiviral compounds: characterization and application to the isolation of antivirals from traditional medicinesJ Gen Virol200889Pt 118819418089742
   PubMedGoogle Scholar
• ColpittsCCSchangLMA small molecule inhibits virion attachment to heparin sulfate- or sialic acid-containing glycansJ Virol201488147806781724789779
   PubMed Web of Science ®Google Scholar
• LeytonLHottMAcunaFNutraceutical activators of AMPK/Sirt1 axis inhibit viral production and protect neurons from neurodegenerative events triggered during HSV-1 infectionVirus Res2015205637226031763
   PubMed Web of Science ®Google Scholar
• SartoriGJardimNSMarcondes SariMHAntiviral action of diphenyl diselenide on herpes simplex virus 2 infection in female BALB/c miceJ Cell Biochem201611771638164826639776
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER)Guidance for industry, E 10 choice of control group and related issues in clinical trials2001 Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm073139.pdfAccessed August 16, 2016
   Google Scholar
• CalvertMKyteDDuffyHPatient-reported outcome (PRO) assessment in clinical trials: a systematic review of guidance for trial protocol writersPLoS One2014910e11021625333995
   PubMed Web of Science ®Google Scholar
• VodickaEKimKDevineEBGnanasakthyAScogginsJFPatrickDLInclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials.gov (2007–1013)Contemp Clin Trials2015431925896116
   PubMed Web of Science ®Google Scholar
• WillkeRJBurkeLBEricksonPMeasuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labelsControl Clin Trials200425653555215588741
   PubMedGoogle Scholar